Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The lapse in government funding notice has been removed from the page, and other content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-15T15:06:38.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Publications and results related to KEYNOTE-564 were added, including a 2024 NEJM article, and the study record dates were updated.
    Difference
    0.1%
    Check dated 2025-11-01T07:29:45.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    Added a time-sensitive operating status notice and funding-related disclaimer, and updated the version to v3.2.0 (removing v3.1.0).
    Difference
    1%
    Check dated 2025-10-03T08:50:29.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page updated to v3.1.0 and removed several MedlinePlus drug-safety topics (Drug Safety, Substandard Drugs, Counterfeit Drugs), signaling a reorientation or narrowing of content rather than new information.
    Difference
    0.3%
    Check dated 2025-09-26T04:24:47.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    - The only change is the deletion of the 'Back to Top' link; no core content, pricing, or time-sensitive information appears to be added or removed.
    Difference
    0.0%
    Check dated 2025-09-18T21:39:04.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Version bump: updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no other content changed.
    Difference
    0.0%
    Check dated 2025-09-11T16:47:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.